Perelman School of Medicine

By Erica AndersenDentists and physicians practice health care from different perspectives, however, the oral and general health of their patients are of primary importance to both types of providers. A new online course taught by University of Pennsylvania faculty seeks to highlight the inextricable connections between the two professions.

Chantell Evans, PhD, a postdoctoral fellow in the Perelman School of Medicine at the University of Pennsylvania, has been selected by the Howard Hughes Medical Institute (HHMI) as one of 15 early-career scientists in its first cohort of HHMI Hanna Gray Fellows.

The University of Pennsylvania’s Laboratory for Research on the Structure of Matter has been awarded a six-year, $22.6 million center grant from the National Science Foundation to support LRSM’s work in cutting-edge materials.

What if with the click of a button, a clinician could improve and personalize a patient’s treatment for a mental illness like post-traumatic stress disorder, depression or panic disorder?

To help college-bound youth who have lived in foster care Cabrini University, Community College of Philadelphia, Temple University and West Chester University have partnered with the Field Center for Children

The 2017 Atlantic hurricane season, which runs through November, has already seen two of the strongest storms on record, with hurricanes Irma and Harvey bringing extreme winds, torrential rain and significant flooding to the population centers in their paths.

George Demiris has been named the University of Pennsylvania’s 22nd Penn Integrates Knowledge University Professor.

This summer, Christeen Samuel, a sophomore at the University of Pennsylvania from New York City, spent 10 weeks in western Germany using technology to observe how the brain changes when a person makes an impulsive, aggressive choice, such as road rag

Investigators at the Perelman School of Medicine and CHOP, who together led research, development, and clinical trials of the new therapy in collaboration with Novartis, hail the FDA’s approval as a game changer for the treatment of younger patients battling the aggressive blood cancer and a pivotal milestone in this new era of cellular therapies.

In his office at the University of Pennsylvania, oral and maxillofacial surgeon Rabie Shanti sits at his computer, clicking through photos of patients he’s operated on.He pulls up an image of a mouth open wide, tongue extended.